US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (193)
  • Diseases & Conditions (3845)
  • Drug Delivery (175)
  • Therapeutic Area (6091)
  • Vaccines (594)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2014
11/30/2014 | published by: Global Markets Direct
... research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Hisamitsu Pharmaceutical Co., Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...  |  read more...
USD 1,500
Sorrento Therapeutics, Inc. - Product Pipeline Review - 2014
11/30/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sorrento Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics
12/1/2014 | published by: Current Partnering
... entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter asset purchase deals. Understanding the flexibility of a prospective partner’s negotiated deals terms ...  |  read more...
USD 2,995
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
12/1/2014 | published by: Current Partnering
... royalty financing deals. Comprehensive directory of royalty financing deals since 2007 Royalty financing contract documents Royalty financing agreement terms Royalty financing agreement structure Top royalty financing deals by value Most active Royalty financing dealmakers The ...  |  read more...
USD 1,995
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
12/1/2014 | published by: Current Partnering
... manufacturing and supply agreements entered into by the world’s biopharma companies. The report provides a detailed understand and analysis of how and why companies enter manufacturing and supply deals. Understanding the flexibility of a prospective ...  |  read more...
USD 3,295
OTC Medications in Finland (2014) – Market Sizes
12/1/2014 | published by: Mintel - Snapshots
... products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Finland is given in EUR with a minimum of ...  |  read more...
USD 600
Vitamins & Minerals in Vietnam (2014) – Market Sizes
12/2/2014 | published by: Mintel - Snapshots
... but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in Vietnam is given in VND with a minimum of five years' historical ...  |  read more...
USD 600
OTC Medications in Vietnam (2014) – Market Sizes
12/2/2014 | published by: Mintel - Snapshots
... products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Medications in Vietnam is given in VND with a minimum of ...  |  read more...
USD 600
Vitamins & Minerals in Germany (2014) – Market Sizes
12/3/2014 | published by: Mintel - Snapshots
... but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in Germany is given in EUR with a minimum of five years' historical ...  |  read more...
USD 600
Gastric Ulcers - Pipeline Review, H2 2014
12/15/2014 | published by: Global Markets Direct
... therapeutic development for Gastric Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Japanese Encephalitis - Pipeline Review, H2 2014
12/15/2014 | published by: Global Markets Direct
... therapeutic development for Japanese Encephalitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cancer Vaccine Partnering Terms and Agreements
12/1/2014 | published by: Current Partnering
... in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer vaccine partnering contract documents Top cancer vaccine deals by value The Cancer Vaccine Partnering Agreements report provides an understanding ...  |  read more...
USD 1,995
Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325411
12/10/2014 | published by: Plunkett Research, Ltd.
... will save countless hours of research. Key Findings: Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry, including Average ...  |  read more...
USD 1,995
Seikagaku Corporation - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Seikagaku Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Spring Bank Pharmaceuticals, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Spring Bank Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...  |  read more...
USD 1,500
Eagle Pharmaceuticals Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Eagle Pharmaceuticals Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Griffin Discoveries BV - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Griffin Discoveries BV’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Kolltan Pharmaceuticals, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Kolltan Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Meiji Seika Pharma Co., Ltd. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... Co., Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Meiji Seika Pharma Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug ...  |  read more...
USD 1,500
Parion Sciences, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Parion Sciences, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
SymBio Pharmaceuticals Limited - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of SymBio Pharmaceuticals Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Taisho Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Taisho Pharmaceutical Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...  |  read more...
USD 1,500
Valens Therapeutics, Inc. - Product Pipeline Review - 2014
12/15/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Valens Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Bangladesh Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... non-communicablediseases, this represents an epidemiological transition that will present new opportunities forpharmaceutical companies. Headline Expenditure Projections Pharmaceuticals: BDT138.81bn (USD1.78bn) in 2013 to BDT154.62bn (USD1.99bn) in 2014; +11.4%in local currency terms and +11.9% in US dollar ...  |  read more...
USD 1,295
India Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... reform willhelp unlock the potential of the large Indian market. Headline Expenditure Projections Pharmaceuticals: INR904.0bn (USD15.4bn) in 2013 to INR1,021.8bn (USD17.0bn) in 2014; +13.0% inlocal currency terms and +10.36% in US dollar terms. Healthcare: INR4,640bn ...  |  read more...
USD 1,295
< prev 1    3  4  5  6  7  8  9  10